Elsevier,
Adsorption through Advanced Nanoscale Materials: Applications in Environmental Remediation, Volume , 1 January 2023
This chapter aligns with Goal 6: Clean water and sanitation by reviewing the role of nanostructured materials as a promising alternative to conventional methods and is effective in eliminating water and wastewater contaminants, such as inorganics (toxic metals), organics, and microorganisms.
Elsevier,
Clinical Immunology (Sixth Edition)
Principles and Practice
2023, Pages 361-374
This content aligns with Goal 3: Good Health and Wellbeing by providing a current understanding of the cellular and molecular basis of mammalian antifungal immunity, which shows promise for guiding immunotherapy and vaccination strategies for at-risk patients, including those with HIV/AIDS.
Elsevier,
Renewable Energy - Volume 2: Wave, Geothermal, and Bioenergy Definitions, Developments, Applications, Case Studies, and Modelling and Simulation, Volume , 1 January 2023
This chapter aligns with SDGs 7 and 11, by describing the role and possibilities of wave energy to help support global (sustainable) energy systems.
Elsevier,
Viral, Parasitic, Bacterial, and Fungal Infections: Antimicrobial, Host Defense, and Therapeutic Strategies, 2023, Pages 757-770
This content aligns with Goal 3: Good Health. As per World Health Organization (WHO) recommendations, it is required to implement the evaluation studies of ethnomedicines for HIV/AIDS, malaria, tuberculosis, and other infectious treatments, to find effective and economical therapeutic agents.
Elsevier,
Clinical Immunology (Sixth Edition)
Principles and Practice
2023, Pages 832-842
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by advancing understanding of MG pathophysiology to improve current therapies and contribute to the development of novel, MG-specific therapeutics.
Elsevier,
Clinical Immunology (Sixth Edition): Principles and Practice, 2023, Pages 972-982
This content aligns with Goal 3: Good Health, this chapter aims at elucidating the main characteristics of AIH, PBC, and PSC, with particular interest for the clinical manifestations, pathogenesis, autoantibodies, and therapeutic options.
